Drug Database
ME
meningococcal vaccine (Menomune / MPSV4)
✓ ApprovedSanofi S.A · Vaccine · Vaccine
What is meningococcal vaccine?
meningococcal vaccine is a vaccine developed by Sanofi S.A. It is approved for therapeutic indications via injectable (others) or intradermal injection or subcutaneous injection.
Drug Profile
| Brand Names | Menomune, MPSV4 |
| Company | Sanofi S.A |
| Drug Class | Vaccine |
| Route | Injectable (Others), Intradermal Injection, Subcutaneous Injection |
| Status | Approved |
Sources: ClinicalTrials.gov, Sanofi S.A
Therapeutic Indications
meningococcal vaccine is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Infections and infestations | Meningococcal bacteraemia | ✓ Approved |
Related Research Articles
Unable to load articles right now.